IOL Chemicals & Pharmaceuticals is currently trading at Rs. 305.20, up by 6.35 points or 2.12% from its previous closing of Rs. 298.85 on the BSE.
The scrip opened at Rs. 310.60 and has touched a high and low of Rs. 321.90 and Rs. 301.20 respectively. So far 234004 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 321.90 on 29-Apr-2020 and a 52 week low of Rs. 147.35 on 25-Mar-2020.
Last one week high and low of the scrip stood at Rs. 321.90 and Rs. 264.00 respectively. The current market cap of the company is Rs. 1737.91 crore.
The promoters holding in the company stood at 41.89%, while Institutions and Non-Institutions held 1.75% and 56.36% respectively.
IOL Chemicals & Pharmaceuticals has been recognized as a Three Star Export House by the Ministry of Commerce & Industry, Government of India and accordingly a Three Star Export House Recognition Certificate has been issued to the Company in accordance with the provisions of the Foreign Trade Policy 2015?2020 by upgrading its Two Star Export House Status. The certificate shall be valid for a period of five years. This will facilitate the company to expand its product portfolio in the Foreign Market.
IOL Chemicals & Pharmaceuticals is a leading organic chemicals manufacturer and supplier in India.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: